Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07660536 · ClinicalTrials.gov registry record · Phase 2
To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study
A Phase 2 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT07660536: Completed Phase 2 study, sponsored by Creighton University.
NCT07660536 is a Phase 2 study that has completed, run by Creighton University. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07660536, a Phase 2 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
A clinical trial to compare the effect of doxercalciferol or placebo in preventing bone loss from the spine and femur in postmenopausal women
Primary Outcome
measurements every 6 months over 2 years
Interventions
- DRUG doxercalciferol capsules, Hectorol®
- DRUG Matched Placebo (Capsules)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 1989-11-14 |
| Est. Completion | 1994-12-23 |
| Phase | Phase 2 |
What the finished NCT07660536 record still lists
NCT07660536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which doxercalciferol capsules, Hectorol® is the first listed.
NCT07660536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07660536 about?
NCT07660536 is a clinical study titled "To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study". A clinical trial to compare the effect of doxercalciferol or placebo in preventing bone loss from the spine and femur in postmenopausal women
What is the current status of trial NCT07660536?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 1989-11-14. Estimated completion is 1994-12-23.
What interventions are being tested in trial NCT07660536?
The interventions under investigation include: doxercalciferol capsules, Hectorol® (DRUG), Matched Placebo (Capsules) (DRUG).
Who is sponsoring clinical trial NCT07660536?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07660536's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI